BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31794280)

  • 21. Programming apoptosis and autophagy with novel approaches for diabetes mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(2):173-88. PubMed ID: 25742566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease.
    Maiese K
    Neural Regen Res; 2015 Apr; 10(4):518-28. PubMed ID: 26170801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.
    Maiese K
    Curr Neurovasc Res; 2016; 13(4):329-340. PubMed ID: 27488211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel directions for diabetes mellitus drug discovery.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Expert Opin Drug Discov; 2013 Jan; 8(1):35-48. PubMed ID: 23092114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
    Maiese K
    Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Impairment in Multiple Sclerosis.
    Maiese K
    Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
    Maiese K
    Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin and diabetes mellitus.
    Maiese K
    World J Diabetes; 2015 Oct; 6(14):1259-73. PubMed ID: 26516410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
    Maiese K
    Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell guidance through the mechanistic target of rapamycin.
    Maiese K
    World J Stem Cells; 2015 Aug; 7(7):999-1009. PubMed ID: 26328016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems Level Understanding of Circadian Integration with Cell Physiology.
    Morris AR; Stanton DL; Roman D; Liu AC
    J Mol Biol; 2020 May; 432(12):3547-3564. PubMed ID: 32061938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian target of rapamycin signaling in diabetic cardiovascular disease.
    Chong ZZ; Maiese K
    Cardiovasc Diabetol; 2012 Jul; 11():45. PubMed ID: 22545721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.
    Maiese K
    Neural Regen Res; 2021 Mar; 16(3):448-455. PubMed ID: 32985464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):332-337. PubMed ID: 32334502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin: new directions for the nervous system.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Int J Mol Sci; 2012; 13(9):11102-11129. PubMed ID: 23109841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The trilateral interactions between mammalian target of rapamycin (mTOR) signaling, the circadian clock, and psychiatric disorders: an emerging model.
    Singla R; Mishra A; Cao R
    Transl Psychiatry; 2022 Aug; 12(1):355. PubMed ID: 36045116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling pathway cross talk in Alzheimer's disease.
    Godoy JA; Rios JA; Zolezzi JM; Braidy N; Inestrosa NC
    Cell Commun Signal; 2014 Mar; 12():23. PubMed ID: 24679124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.
    Van Skike CE; Galvan V
    Gerontology; 2018; 64(3):205-211. PubMed ID: 29320772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTOR signaling regulates central and peripheral circadian clock function.
    Ramanathan C; Kathale ND; Liu D; Lee C; Freeman DA; Hogenesch JB; Cao R; Liu AC
    PLoS Genet; 2018 May; 14(5):e1007369. PubMed ID: 29750810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.